Medline Inc. · MDLN · Next earnings

Medline Inc. next earnings report

MDLN's next report date is not on the calendar yet. Here is where the last quarter left off and what remains open. Last quarter: Medline Raises 2026 Organic Sales Outlook on 10% Q3 Growth

Date not yet scheduled Healthcare

What the street expects

Consensus for the coming report
Consensus EPS — Calendar consensus
Consensus revenue — Calendar consensus
Report date TBD Not yet on the calendar
Session — Session not yet known

Where MDLN left off: FY2026 Q3

Full report

Medline Raises 2026 Organic Sales Outlook on 10% Q3 Growth

EPS surprise — Reported — vs $0.34
Revenue surprise — Reported — vs $7.72B
Stock move +16.2% Event window
Subsequent drift 0.0% Up to 20 sessions

Raised 2026 organic-sales guidance to 10–10.5%; adjusted EBITDA guidance was reaffirmed.

What to watch on the call

Carried forward from the last transcript

Risks management flagged

  • Elevated inflation in raw materials, diesel and finished goods could pressure margins.
  • Supply Chain Solutions margins may be affected by low-margin prime-vendor rebates.
  • Ongoing quality work, potential product exits or FDA actions, and uncertainty around fire-related insurance recovery remain risks.

Questions analysts left open

  • Magnitude of inflationary costs and diesel-price assumptions.
  • Pricing leverage in existing contracts and timing of price increases.
  • Supply Chain Solutions margin outlook and rebate structures.
  • Scalability of the Canada prime-vendor model and potential additional quality-related product exits.

Ask FN2 about MDLN next report

Transcript, numbers and history already loaded
What should I watch for in MDLN's next earnings report?How did MDLN guide last quarter, and is consensus above or below that?Give me the bull and bear case going into MDLN earnings.

Free account. Your question opens in FN2 with this report's transcript and numbers attached.

Get the MDLN recap when the next report posts

One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.

Recent MDLN quarters

All MDLN earnings
+16.2%FY2026 Q3

Sources

  1. FN2 corporate events calendar, resolved from the earnings calendar feed
  2. FN2 earnings calendar analyst consensus
  3. Earnings call transcript analysis, FY2026 Q3

Methodology

The report date comes from FN2's resolved corporate-events calendar and is marked estimated until the company confirms it. Consensus figures are the calendar's latest analyst estimates for the fiscal period and are not an FN2 forecast.

Risks and open questions are carried forward verbatim from FN2's structured analysis of the previous earnings call. Missing values stay missing and are never estimated.

By FN2 Research · Updated . For educational purposes only; not investment advice.